Opiant Pharmaceuticals, Inc. EPS - Earnings per Share 2014-2022 | OPNT
Opiant Pharmaceuticals, Inc. eps - earnings per share from 2014 to 2022. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Opiant Pharmaceuticals, Inc. Annual EPS |
| 2021 |
$0.51 |
| 2020 |
$-0.44 |
| 2019 |
$2.17 |
| 2018 |
$-7.10 |
| 2017 |
$0.00 |
| 2017 |
$2.94 |
| 2016 |
$-4.09 |
| 2015 |
$-3.88 |
| 2014 |
$-6.57 |
| 2013 |
$-0.06 |
| Opiant Pharmaceuticals, Inc. Quarterly EPS |
| 2022-09-30 |
$-1.93 |
| 2022-06-30 |
$-2.31 |
| 2022-03-31 |
$-2.43 |
| 2021-12-31 |
$0.30 |
| 2021-09-30 |
$0.56 |
| 2021-06-30 |
$0.31 |
| 2021-03-31 |
$-0.66 |
| 2020-12-31 |
$-0.14 |
| 2020-09-30 |
$0.15 |
| 2020-06-30 |
$-0.05 |
| 2020-03-31 |
$-0.40 |
| 2019-12-31 |
$0.33 |
| 2019-09-30 |
$1.97 |
| 2019-06-30 |
$0.31 |
| 2019-03-31 |
$-0.44 |
| 2018-12-31 |
$-2.58 |
| 2018-09-30 |
$-0.32 |
| 2018-06-30 |
$-0.52 |
| 2018-03-31 |
$-3.68 |
| 2017-12-31 |
$0.00 |
| 2017-10-31 |
$-2.77 |
| 2017-09-30 |
$-1.68 |
| 2017-07-31 |
$0.00 |
| 2017-06-30 |
$0.11 |
| 2017-04-30 |
$-1.55 |
| 2017-03-31 |
$-1.39 |
| 2017-01-31 |
$4.91 |
| 2016-10-31 |
$-0.30 |
| 2016-07-31 |
$0.00 |
| 2016-04-30 |
$0.15 |
| 2016-01-31 |
$1.52 |
| 2015-10-31 |
$-6.00 |
| 2015-07-31 |
$0.00 |
| 2015-04-30 |
$-1.01 |
| 2015-01-31 |
$-1.54 |
| 2014-10-31 |
$-0.43 |
| 2014-07-31 |
$0.00 |
| 2014-04-30 |
$-0.31 |
| 2014-01-31 |
$-2.96 |
| 2013-10-31 |
$-0.01 |
